Clinical Trials Logo

Clinical Trial Summary

to report our patients' outcomes of SNM in tertiary health centres in Turkey


Clinical Trial Description

We retrospectively analyzed 18 patients who underwent SNM for urinary or bowel dysfunction between 2017 and 2022 in our clinic. We excluded 2 patients due to non-effective responses after the test period. After local ethics committee approval was obtained from our institute (Number and date: 21-12.1T/14). Patient characteristics and demographic data including age, gender, indications to the SNM, age at diagnosis, and comorbidities were collected from our Hospital patients' record system. Urinary functions were evaluated by the ICIQ-SF questionnaire form. Patients' diagnosis, implantation duration, complications, and improvement of symptoms were recorded. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06098963
Study type Observational [Patient Registry]
Source Cigli Regional Training Hospital
Contact
Status Completed
Phase
Start date January 1, 2017
Completion date January 1, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05380856 - Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction N/A
Not yet recruiting NCT06434831 - Evaluation of Autonomic Nervous System Changes in Response to Stimulation by Sacral Neuromodulation N/A
Terminated NCT02357784 - Sacral Neuromodulation in Dual Incontinence: Ultrasound and Afferent Nerve Sensation Assessment N/A
Active, not recruiting NCT05543382 - Cycling Study With the Axonics System
Not yet recruiting NCT05903105 - Diversity in Patients With OAB
Completed NCT00959296 - Implantable Systems Performance Registry N/A